Should I stop dapagliflozin (SGL‑2 inhibitor) before my upcoming surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, Stop Dapagliflozin at Least 3 Days Before Surgery

Dapagliflozin must be discontinued at least 3 days (≥72 hours) before your scheduled surgery to reduce the risk of perioperative metabolic acidosis and euglycemic ketoacidosis. 1, 2, 3

Timing of Discontinuation

  • Stop dapagliflozin exactly 3 days before your scheduled procedure 1, 2
  • This recommendation applies regardless of whether you have diabetes, heart failure, or chronic kidney disease 1, 2
  • The FDA drug label explicitly states to "withhold dapagliflozin for at least 3 days, if possible, prior to major surgery or procedures associated with prolonged fasting" 3

Why This Matters: The Ketoacidosis Risk

  • SGLT2 inhibitors like dapagliflozin significantly increase your risk of developing euglycemic ketoacidosis during and after surgery (1.02 vs 0.69 per 1000 patients; OR 1.48) 4
  • This dangerous complication can occur even when your blood glucose levels appear normal (<200 mg/dL), which is why it's called "euglycemic" ketoacidosis 4, 5
  • The drug alters your insulin/glucagon ratio to favor ketone production, and this effect persists even after stopping the medication 4
  • Case reports document ketoacidosis occurring in non-diabetic patients taking dapagliflozin for heart failure who underwent surgery, including one 83-year-old woman who took it on the day of her procedure 5

Critical Warnings

  • The risk exists even if you stop the medication >72 hours before surgery—the risk is a continuum, so stopping earlier is safer 4
  • You can develop ketoacidosis even if you don't have diabetes; this has been documented in heart failure patients 4, 5
  • Emergency surgery carries a much higher ketoacidosis risk (1.1%) compared to elective surgery (0.17%) 4
  • Three cardiac surgery patients who stopped their SGLT2 inhibitors only 1-2 days preoperatively all developed euglycemic ketoacidosis on postoperative day 1 6

Special Considerations for Heart Failure Patients

  • Even though you may be taking dapagliflozin for heart failure management, you must still stop it before surgery 1, 5
  • The American Heart Association gives this a Class 1 (strongest) recommendation specifically for patients with heart failure undergoing surgery 1, 4
  • Your other heart failure medications (ACE inhibitors, beta-blockers, mineralocorticoid antagonists) should generally be continued, but SGLT2 inhibitors are the exception 1, 4
  • Patients with heart failure already have a 3-fold higher perioperative mortality risk (9.2-9.3% vs 2.9%), making metabolic complications even more dangerous 4

Preoperative Preparation (Starting 3 Days Before)

  • Maintain adequate hydration to reduce ketosis risk 4
  • Avoid prolonged fasting when possible 4
  • Your surgical team should monitor capillary glucose and ketones perioperatively 4

When to Restart After Surgery

  • Resume dapagliflozin once you are eating and drinking normally, typically 24-48 hours after surgery 4
  • Do not delay restarting unnecessarily, as this may lead to decompensated heart failure in patients taking it for that indication 4
  • Ensure adequate hemostasis has been achieved before restarting 4

What to Watch For Postoperatively

  • Signs of ketoacidosis include nausea, vomiting, abdominal pain, and general weakness 4, 6
  • These symptoms are non-specific and common after surgery, which is why ketoacidosis is often diagnosed late 6
  • If you develop these symptoms, your medical team should check serum and urine ketones immediately, even if your blood glucose is normal 4, 6

Bottom Line

The evidence is unequivocal: stop dapagliflozin at least 3 days before surgery. This recommendation is endorsed by the American Heart Association, American College of Cardiology, American College of Surgeons, and the American Diabetes Association, and is mandated by the FDA drug label 1, 4, 2, 3. The risk of perioperative ketoacidosis—which can be life-threatening—far outweighs any temporary interruption in your chronic disease management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dapagliflozin Discontinuation Prior to Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Perioperative Management of SGLT2 Inhibitors in Patients with Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

When should a patient with stable renal function and no significant comorbidities discontinue dapagliflozin (SGLT2 inhibitor) prior to undergoing laparoscopic surgery?
What are the considerations for using Dapagliflozin (Forxiga) in patients undergoing surgical procedures?
Does the risk of diabetic ketoacidosis outweigh the benefit of proceeding with cataract surgery in a patient taking SGLT2 (Sodium-Glucose Linked Transporter 2) inhibitors, such as canagliflozin (canagliflozin), given that cataract surgery is considered a low-stress procedure?
Can a patient with type 2 diabetes and stable renal function be given insulin glargine with dapagliflozin (SGLT2 inhibitor) as take-home medications?
Can a patient continue taking Farxiga (dapagliflozin) after spine surgery?
Should I stop dapagliflozin now?
What are the recommended steps for early sepsis management, including fluid resuscitation, antibiotic timing, vasopressor use, source control, and monitoring?
What is the appropriate urgent management for an adult female with systemic lupus erythematosus and Sjögren’s overlap, chronic kidney disease, and a large pericardial effusion?
What is the typical natural history and prognosis of hepatitis B virus infection in adults?
How should I initiate and manage hemodialysis in a patient with systemic lupus erythematosus, including vascular access, dialysis prescription, medication adjustments, laboratory monitoring, and supportive care?
Can a kidney donor who is anti‑HBc total positive donate a kidney?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.